Share this Post!

Manila, Philippines – The Food and Drug Administration (FDA) recently had a meeting with the President, His Excellency Ferdinand Marcos, Jr., and the Private Sector Advisory Council (PSAC) to discuss ways to enhance the country’s healthcare sector.

The FDA is committed to safeguarding public health by ensuring the safety, efficacy, and quality of food, drugs, and medical devices. To achieve this, the FDA works closely with various stakeholders, including the private sector.

During the meeting, the President and the PSAC expressed their support for the FDA’s efforts to improve the healthcare sector and pledged their cooperation in achieving this goal. They also discussed ways to streamline the regulatory process to make it easier for manufacturers and importers to bring their products to market while maintaining safety and quality standards.

The FDA highlighted the importance of public-private partnerships in promoting innovation and ensuring that Filipinos have access to safe and effective healthcare products. The agency also emphasized the need for collaboration among different government agencies to address the challenges facing the healthcare sector.

Overall, the meeting was a productive discussion that underscored the importance of collaboration and cooperation among all stakeholders in the healthcare sector. The FDA looks forward to working closely with the PSAC to achieve its mission of protecting and promoting public health in the Philippines.

Joining President Marcos Jr. are Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate, PhilHealth Acting President and CEO Emmanuel Ledesma Jr., PhilHealth Executive Vice President and Chief Operating Officer (COO) Eli Dino Santos, Presidential Communications Office (PCO) Secretary Cheloy Velicaria-Garafil, Presidential Adviser on Investment and Economic Affairs Secretary Frederick Go, Commission on Higher Education (CHED) Chairperson J. Prospero De Vera IlI and Department of Health (DOH) Officer-in-Charge (OIC) Undersecretary Dr. Maria Rosario Vergeire.

See more:>>https://bit.ly/42SLD56